Key EventTrading window closes for financial results announcement
Sanofi Consumer Healthcare India Limited (SANOFICONR)
·Next Day Close·+1.33%·₹4,568.4
Sanofi Consumer Healthcare India Limited disclosed a SEBI-mandated certificate from its share transfer agent MUFG Intime India Private Limited confirming dematerialisation of securities for the quarter ended June 30, 2026. The filing covers regulatory compliance for share transfers during this period and includes confirmation of security certificate handling and register updates.
Sign up to read summarySanofi Consumer Healthcare India Limited (SANOFICONR)
·Next Day Close·0%·₹4,602.7
The 3rd Annual General Meeting of Sanofi Consumer Healthcare India Limited was held on 26 June 2026, where shareholders approved the adoption of audited standalone financial statements for FY2025, declared a final dividend of Rs. 75 per equity share, reappointed Director Stanislas Camart, appointed Price Waterhouse & Co as statutory auditors, and ratified cost auditor remuneration. All resolutions passed with requisite majority, supported by remote e-voting and e-voting during the meeting, with no invalid or dissenting votes reported.
Sign up to read summarySanofi Consumer Healthcare India Limited (SANOFICONR)
·Next Day Close·0%·₹4,602.7
Sanofi Consumer Healthcare India announced that shareholders approved Price Waterhouse & Co Chartered Accountants LLP as the new statutory auditor at the June 26, 2026 AGM, filling a vacancy and securing a five-year term until the 2031 AGM, replacing Kalyaniwalla & Mistry LLP.
Sign up to read summarySanofi Consumer Healthcare India Limited (SANOFICONR)
·Next Day Close·-0.64%·₹4,602.8
Sanofi Consumer Healthcare India Limited announced that its trading window will close on 1 July 2026 for the declaration of unaudited standalone financial results for the quarter and half year ended 30 June 2026, remaining closed until 48 hours post-announcement.
Sign up to read summarySanofi Consumer Healthcare India Limited (SANOFICONR)
·Next Day Close·-0.64%·₹4,602.8
Sanofi Consumer Healthcare India held its 3rd Annual General Meeting on 26 June 2026 via video conference, approving the 2025 audited standalone financial statements, declaring a final dividend of Rs 75 per equity share, reappointing Director Stanislas Camart, appointing Price Waterhouse & Co as statutory auditors, and ratifying cost auditor remuneration. Chairman Amit Jain chaired the session, with 12 shareholder queries addressed during a Q&A. The meeting concluded at 5:10 p.m. IST after enabling final e-voting.
Sign up to read summarySanofi Consumer Healthcare India Limited (SANOFICONR)
·Next Day Close·+1.29%·₹4,770.6
Sanofi Consumer Healthcare India Limited announced its 3rd Annual General Meeting on 26 June 2026 at 3:00 PM IST via video conferencing, where shareholders will adopt audited financial statements for FY 2025 and approve a final dividend of ₹75 per share. The meeting will cover statutory auditor appointments including Price Waterhouse & Co for regular and casual vacancies, and Kishore Bhatia & Associates as cost auditor, with remuneration details disclosed. Shareholders can participate remotely through NSDL and CDSL platforms with specific login formats, and dividend payments will be made electronically to eligible holders recorded as of 19 June 2026.
Sign up to read summarySanofi Consumer Healthcare India Limited (SANOFICONR)
·Next Day Close·-0.58%·₹4,737.15
Sanofi Consumer Healthcare India announced the resignation of statutory auditor Kalyaniwalla & Mistry LLP effective April 30, 2026, citing commercial unviability at reduced fee levels after their five-year term began April 25, 2024. The resignation follows a fee increase request denied by the company, with no quality concerns raised. The auditor submitted formal notice to the board and requested placement before upcoming Audit Committee and Board meetings.
Sign up to read summarySanofi Consumer Healthcare India Limited (SANOFICONR)
·Next Day Close·-0.58%·₹4,737.15
Sanofi Consumer Healthcare India Limited reported Q1 2026 revenue of ₹2,292 MN, up 33% year-on-year, with net profit at ₹678 MN, reflecting a 36% increase, driven by domestic sales growth of 15.5% and export surge of 144% following product relaunches.
Sign up to read summarySanofi Consumer Healthcare India Limited (SANOFICONR)
·Next Day Close·+2.66%·₹4,799.15
The Board of Directors of Sanofi Consumer Healthcare India Limited approved the unaudited financial results for the quarter ended March 31, 2026 during its meeting on April 28, 2026, alongside adopting related reports and disclosures under SEBI regulations.
Sign up to read summary